Amylyx Pharmaceuticals, Inc. (AMLX) Tops Q1 EPS by 20c

Amylyx Pharmaceuticals, Inc. (NASDAQ: AMLX) reported Q1 EPS of ($0.42), $0.20 better than the analyst estimate of ($0.62).

For earnings history and earnings-related data on Amylyx Pharmaceuticals, Inc. (AMLX) click here.

You May Also Be Interested In

• BofA maintains underperform ratings on six BDC stocks
• Is the global equity rally broadening? UBS weighs in
• Wolfe Research sees CNH stock flat 2027 outlook on commodity prices